J. Huang

发表

Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia

Elaine Holmes, Jeremy K Nicholson, Dagmar Koethe, 2006, PLoS medicine.

Profiling of CSF: Author's Reply

S. Bahn, F. Leweke, J. Huang, 2006, PLoS Medicine.

CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis

J. Klosterkötter, E. Holmes, S. Bahn, 2007, PloS one.

Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset Psychosis

D. Oxley, S. Bahn, F. Leweke, 2006, PLoS medicine.

Increased α-Defensins as a Blood Marker for Schizophrenia Susceptibility*

Edmund S. Jackson, E. Torrey, S. Bahn, 2008, Molecular & Cellular Proteomics.

CSF biomarker discovery using label-free nano-LC-MS based proteomic profiling: technical aspects.

Emanuel Schwarz, Chris Hughes, Sabine Bahn, 2007, Journal of separation science.

Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients.

Elaine Holmes, Sabine Bahn, E. Holmes, 2006, Journal of proteome research.

Selecting pre‐screening items for early intervention trials of dementia—a case study

Lang Li, Jeffrey Huang, Siu L Hui, 2004, Statistics in medicine.

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

R. Yolken, N. Karp, M. Webster, 2004, Molecular Psychiatry.

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder

E Holmes, H. Manji, J. Griffin, 2009, Molecular Psychiatry.

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

H. Lockstone, D. Oxley, K. Lilley, 2008, Molecular Psychiatry.